Final Thoughts: You Dont Have to Take a GLP-1 to Lose Weight GLP-1s can be helpful tools for some people, but theyre not the only way forward
More recently, encouraging clinical results from a triple-hormone-receptor agonist, Retatrutide, and several GLP-1R/GCGR dual agonists, suggest that GCGR could be a promising co-stimulating target for type 2 diabetes and obesity
Will I be on these medications forever
As is reflective of the wider under-recognition of women in science, women's contributions to the development of GLP-1 drugs have taken time to be fully appreciated (Barany, Barany)
The Wegovy pill is not the only option at Hims & Hers, but the platform promotes it as the default first recommendation
Clinically, both Mounjaro and Zepbound incorporate tirzepatide, using a dual-action receptor approach that enhances insulin response and curbs appetite